Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2001
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140984A1 Selective inhibitors of mmp-12
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140934A1 BENZISOXAZOLES AND PHENONES AS $g(a) 2?-ANTAGONISTS
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140900A2 Pyrazole compounds and uses thereof
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140861A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140805A1 Amido polybiguanides and the use thereof as antimicrobial agents
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140289A1 Method for prevention and treatment of cancer and other cell proliferative diseases with ultrasonic energy
10/10/2001EP1140175A2 Antibodies to truncated vegf-d and uses thereof
10/10/2001EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof
10/10/2001EP1140172A1 The prevention and treatment for retinal ischemia and edema
10/10/2001EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders
10/10/2001EP1140158A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/10/2001EP1140150A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/10/2001EP1140134A1 Agent for treating visual cell function disorder
10/10/2001EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
10/10/2001EP1140110A2 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
10/10/2001EP1140098A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140080A1 Use of riluzole for treating acoustic traumas
10/10/2001EP1140078A2 Benzimidazole vascular damaging agents
10/10/2001EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
10/10/2001EP1140065A1 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/10/2001EP1140021A1 Improved formulation for topical non-invasive application in vivo
10/10/2001EP1140016A1 Composition set and kit for use in intraocular surgery
10/10/2001EP0922044B1 Pyrrolo(3,2-c) quinoline derivatives
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001CN1316998A Thiobenzimidazole derivatives
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316906A Stable liquid formulations of botulinum toxin
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/10/2001CN1072505C Novel antibody system for biological response modifiers
10/09/2001US6300334 Thieno[2,3-d]pyrimidine-2,4-diones
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072829A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
10/04/2001WO2001072782A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072714A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072692A1 Malonamic acids and derivatives thereof as thyroid receptor ligands
10/04/2001WO2001072281A2 Microspheres for active embolization
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001WO2001019322A3 Use of csaids in rhinovirus infection
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1137773A2 Growth factor homolog zvegf3
10/04/2001EP1137659A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137621A1 Aldose reductase inhibitors and pharmaceutical compositions
10/04/2001EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/04/2001EP1137415A1 Myt1 kinase inhibitors
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP0809635B1 Alpha-substituted hydrazides having calpain inhibitory activity
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404528A1 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
10/04/2001CA2404461A1 Human g-protein coupled receptors
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/04/2001CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001CA2402735A1 Human transcription factors
10/04/2001CA2401638A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/04/2001CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions
10/03/2001CN1315862A Medicinal compositions for treating eye diseases
10/03/2001CN1315191A Oral liquid for clearing heat and detoxicating and its preparing process
10/03/2001CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists
10/02/2001US6297375 4-phenyl-pyridine derivatives
1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 531